Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Sunday, September 28

5:15 PM - 5:25 PM PT

143 - Accelerated Partial Breast Irradiation to 40 Gy in 10 Daily Fractions: Long-Term Results of a Phase II Study
Speaker: Lapen, Kaitlyn, MD - Memorial Sloan Kettering Cancer Center, New York, NY
5:15 PM - 5:25 PM PT

149 - Quality of Life after Adjuvant or Salvage Radiotherapy Following Radical Prostatectomy: A Secondary Analysis of the TROG 08.03 RAVES Randomized Controlled Trial
Speaker: Smith, Justin, MBBS - Princess Alexandra Hospital, Woolloongabba, QLD
5:15 PM - 5:25 PM PT

155 - A Phase IV Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) as a Standard of Care in Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma
Speaker: Hidalgo, Cecelia - Mayo Clinic, Scottsdale, AZ
5:15 PM - 5:25 PM PT

161 - Evaluating the Relationship of Baseline Skin Pigmentation Phenotype on the Evolution of Radiation Dermatitis
Speaker: Yoder, Alison, MD, MPH - MD Anderson Cancer Center, Houston, TX
5:15 PM - 5:25 PM PT

168 - Advancing 3D MRI Foundation Models for Enhanced MR Image Analysis
Speaker: Yang, Xiaofeng, PhD - Emory University, Atlanta, GA
5:15 PM - 5:25 PM PT

174 - Long-Term Failure Patterns and Prognostic Factors in a Randomized Dose-Escalation Trial for Skull Base Chordomas: A Secondary Analysis from PROG 85-26
Speaker: Ioakeim-Ioannidou, Myrsini, MD - Massachusetts General Hospital, Boston, MA
5:25 PM - 5:35 PM PT

144 - Early Outcomes of a Phase III Randomized Controlled Trial Comparing Ultra-Hypo Fractionated 5 Fraction Treatment vs. Hypofractionated 15 Fraction Treatment for Patients Receiving Regional Nodal Irradiation
Speaker: Vargas, Carlos, MD - Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ
5:25 PM - 5:35 PM PT

150 - Safety and Efficacy of POstoPerative Ablative RadioTherapy (POPART) for Post-Prostatectomy Biochemical Recurrence
Speaker: Ferrario, Federica, MD - University of Milan Bicocca - School of Medicine and Surgery, Milan
5:25 PM - 5:35 PM PT

156 - Long-Term Outcomes Following Substantial De-Escalation of Elective Radiotherapy Dose and Volume in Patients Treated with Definitive Chemoradiotherapy for HPV-Associated Oropharyngeal Cancer
Speaker: Safavi, Amir, MD, MSc - Memorial Sloan Kettering Cancer Center, New York, NY
5:25 PM - 5:35 PM PT

162 - Is Patient-Reported Baseline Fatigue Associated with Overall Survival Among Patients with Resected Head of the Pancreas Adenocarcinoma on NRG Oncology/RTOG 0848?
Speaker: Kachnic, Lisa, MD, FASTRO - Columbia University Medical Center, New York, NY
5:25 PM - 5:35 PM PT

169 - Automating Head-and-Neck Cancer Intensity Modulated Radiation Therapy Treatment Planning with a ReAct Large Language Model Agent
Speaker: Yang, Dongrong, MS, BS - Duke University Medical Center, Durham, NC
5:25 PM - 5:35 PM PT

175 - Surgical Graft and Flap Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma
Speaker: Yang, Noel, MS - MD Anderson Cancer Center, Houston, TX